Dr. Heckman’s research program focuses on developing, evaluating, and disseminating innovative interventions to improve cancer risk and risk-reduction behaviors, primarily related to skin cancer.
A Multi-Level Investigation of US Indoor Tanning Policy Enactment, Implementation, Compliance, Impact, and Economics.
Funded by the National Cancer Institute
Role: Multiple Principal Investigator
This lab has been funded by the following:
- NIH, R01CA244370, A Multi-Level Investigation of US Indoor Tanning Policy Enactment, Implementation, Compliance, Impact, and Economics, 6/1/20-5/31/25, 2nd percentile, $520,103 direct for year 1.
- NIH, R01 CA204271-01A1, Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2): A Hybrid Type 2 Dissemination/Effectiveness Trial, 12/2016-11/2021, 4th percentile, $379,417 direct for year 1.
- Pfizer #WI206759 - ASPIRE US Rheumatology and Dermatology Competitive Research Grant Awards, Interactive Toolbox of Comprehensive Health Resources to Enhance Living with Itch – Educational Facilitation, 2/2016-2/2019, $49,930 direct for year 2.
- NIH, R01CA154928-01, A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors among Young Adults, 3/2011-2/2015, 10th percentile, $261,454 direct for year 4.
- NIH, R21CA134819, Project BRITE: Biopsychosocial Relationships in Indoor Tanning Experiences, 7/2010-6/2012, 6th percentile, $123,800 direct for year 2.
- NIH, R03CA136007, Project INCITE: Investigating Novel Correlates of Indoor Tanning Experiences, 10/2009-6/2012, $50,000 direct for year 2.
- NIH, K07 CA108685, Skin Savvy Study: A Skin Cancer Prevention Intervention, 7/2005-6/2010, $133,500 direct for year 5.
- American Cancer Society IRG# 92-027-16, Risk Assessment Program – Tobacco, 10/2009-9/2010, $30,000 direct for year 1.